Galectin-1, a novel promising target for outcome prediction and treatment in SCLC-Reference-Cited by-同舟云学术

Galectin-1, a novel promising target for outcome prediction and treatment in SCLC

Published:2022-12 Issue: Volume:156 Page:113987
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Corral Juan Manuel,Puerto-Nevado Laura del,Cedeño Mabel,Río-Vilariño Anxo,Mahillo-Fernández Ignacio,Galeano Carlos,Baños Natalia,García-Foncillas Jesús,Dómine Manuel,Cebrián Arancha^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference53 articles.

1. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019);Dómine;Clin. Transl. Oncol.,2020

2. Update on the biology, management, and treatment of small cell lung cancer (SCLC);Saltos;Front. Oncol.,2020

3. Small cell lung cancer from traditional to innovative therapeutics: building a comprehensive network to optimize clinical and translational research;Subbiah;J. Clin. Med.,2020

4. Galectin-1: a small protein with major functions;Camby;Glycobiology,2006

5. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment;Ito;Cancer Metastas-.-. Rev.,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis;Molecular Therapy - Nucleic Acids;2023-09

2. A Novel NCI-H69AR Drug-Resistant Small-Cell Lung Cancer Mini-Tumor Model for Anti-Cancer Treatment Screening;Cells;2023-07-31

3. Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy;Biomolecules;2023-05-29

4. Small cell lung cancer. Has anything changed? Future perspectives;Revisiones en Cáncer;2023